Home > Browse Issues > Vol.48 No.11

Cholesterol Metabolism Reprogramming Shapes the Immune Ecosystem and Therapeutic Response in Liver Cancer: from Metabolic Homeostasis to Immune Vulnerability


LI Wenfeng1,2, WANG Guangchuan1,2*

(1Liver Transplantation Center, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai 200040, China; 1Key Laboratory of Multi-Cell Systems, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China)
Abstract:

HCC (hepatocellular carcinoma) is one of the major malignant tumors worldwide, and its development is closely associated with chronic inflammation, metabolic dysregulation, and immune imbalance. Although immune checkpoint inhibitors and their combination regimens have significantly improved the clinical outcomes of msome patients with advanced HCC, primary and acquired resistance to immunotherapy remains common. Accumulating evidence indicates that aberrant cholesterol metabolism reprograms the metabolic and immunological state of the tumor microenvironment, thereby influencing therapeutic responses in HCC. Rather than merely promoting tumor growth by increasing lipid supply to the tumor cell membrane, cholesterol metabolism reshapes the flux of cholesterol synthesis, uptake, esterification, efflux, and oxidation, converting systemic metabolic status into local immune regulatory signals. This simultaneously affects the metabolic adaptability of tumor cells and the functional

state of immune cells such as T cells, NK cells, and macrophages. This review summarizes cholesterol metabolism reprogramming in HCC and its relationship with hepatic immune surveillance, with particular focus on the functional differences of cholesterol and its derived metabolites across different cell types and subcellular compartments. This article emphasizes that the immunological effects of cholesterol are not simply determined by its absolute levels, but are collectively governed by metabolic flux, cell type, spatial localization, and microenvironmental status. Furthermore, this article summarizes the mechanisms by which cholesterol metabolism maintains redox homeostasis and metabolic resilience in HCC cells, and highlight the role of SOAT1, a cholesterol esterification enzyme, in mediating metabolic buffering that enables tumor resistance to immune attack and recurrence. Finally, this article proposes that future cholesterol metabolism-targeted therapies should shift from merely “lowering cholesterol levels” to “precisely remodeling the metabolic immune ecosystem”—that is, by targeting specific active metabolites and their metabolic nodes to simultaneously relieve immunosuppression and reduce the metabolic resilience of tumor cells against immune attack, thereby improving the efficacy of immunotherapy.



CSTR: 32200.14.cjcb.2026.11.0001